An observational study in General Adult Population and Age 16 and Older, sponsored by Haukeland University Hospital. Recruiting at 1 site in Norway. Open to participants aged 16 Years to 100 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-19.
Sponsored by Haukeland University Hospital · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Psychotherapy aims to modify dysfunctional patterns of thinking, feeling, and behaving to improve mental health. A five-factor model of adaptive behaviors, operationalized in the Things You Do Questionnaire (TYDQ), has been identified as a mediator of treatment response in depression and anxiety interventions. The short-form TYDQ-15 is a key component of a transdiagnostic treatment promoting adaptive behavior. To implement this intervention in Norway, the TYDQ-15 requires translation and cultural adaptation, following established guidelines for clinical assessment instruments. Currently unavailable in Norwegian, its translation and psychometric evaluation are necessary for clinical application. This study aims to (1) produce a culturally adapted Norwegian version of the TYDQ-15 and (2) assess its psychometric properties, including reliability, factor structure, and criterion validity, within a Norwegian population. The findings will facilitate the integration of the Things You Do Intervention into Norwegian mental health services.
Haukeland University Hospital is the lead sponsor of 284 studies on the registry; 58 are open to participants now.
Counted across the registry records on this site, refreshed daily.
General population of Norway
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Things You Do Questionnaire 15-Item Version (TYDQ-15)
The Things You Do Questionnaire - 15 Item Version (TYDQ-15) measures how frequently one engages in adaptive behavior with 15 items scored 0 ("never") to 4 ("every day"). The 15 items are grouped into the five domains of "meaningful activities", "healthy thinking", "goals and plans", "healthy routines", and "social connections. The original English language instrument has been shown to have acceptable psychometric properties across representative population samples.
Time frame: Singe time point, at enrolment.
The Patient Health Questionnaire (PHQ-9)
The Patient Health Questionnaire (PHQ-9) - measures depression severity with nine items scored 0 ("not at all") to 3 ("nearly every day"), corresponding to the criteria for major depression in the DSM-5. The sum of the nine items ranges from 0-27. The scale has demonstrated adequate psychometric properties across different samples and has been found to be sensitive to change in depressive symptoms.
Time frame: Single time point, at enrolment.
The Generalized Anxiety Disorder Scale (GAD-7)
The Generalized Anxiety Disorder Scale (GAD-7) - measures anxiety severity with seven items scored 0 ("not at all") to 3 ("nearly every day") corresponding to symptoms of anxiety disorders. The sum score ranges from 0-21. GAD-7 has demonstrated adequate psychometric properties across different samples and has been found to be sensitive to the presence of anxiety disorders.
Time frame: Single time point, at enrolment.
The Satisfaction with Life Scale (SWLS)
The Satisfaction with Life Scale (SWLS) - measures life-satisfaction with 5 items scored 1 ("strongly disagree") to 7 ("strongly agree"), corresponding to statements of general life satisfaction. Sum scores range from X to Y with higher scores indicating greater life satisfaction. The SWLS has demonstrated adequate psychometric properties across different samples.
Time frame: Single time point, at enrolment.
Plan to share: Undecided — The sharing of IPD for this study will require guaranteed anonymity for all involved participants. Unless such anonymity can be guaranteed, IPD will not be shared outside the research team. Current advances in machine learning and AI introduce difficult questions regarding the possibility of re-identification of research participants from patterns in the data. Decisions of IPD publication therefore require additional consideration.
No publications or documents are linked to this record.
Started Sep 2025 (actual). Primary completion is estimated for Jan 2027, 16 months after the start.
Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 19, 2026: start Mar 2025 → Sep 2025 and primary completion Apr 2026 → Jan 2027.
Earlier changes are on the record history on ClinicalTrials.gov ↗
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Haukeland University Hospital →